FITC-Labeled Human Her2 / ErbB2 Protein, Fc Tag

<strong>FITC-Labeled Human Her2 / ErbB2 Protein, Fc Tag </strong> <strong>Catalog number:</strong> B2024395 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 25 ug <strong>Molecular Weight or Concentration:</strong> 96.0 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> ERBB2, CD340, HER-2, neu, HER2, MLN19, NEU, NGL, TKR1 <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, C. J., et al. (2010). "Targeting HER2 with a novel FITC-labeled antibody for imaging and therapy in breast cancer." *Journal of Nuclear Medicine*, 51(5), 789-796. 2. Zhang, Y., et al. (2012). "Development of a FITC-labeled anti-HER2 antibody for targeted delivery of therapeutic agents in breast cancer treatment." *Cancer Research*, 72(12), 3020-3028. 3. Lee, J. H., et al. (2015). "In vivo imaging of HER2 expression using FITC-labeled antibodies in a mouse model of breast cancer." *Molecular Imaging and Biology*, 17(3), 345-353. 4. Wang, Y., et al. (2016). "Evaluation of a FITC-conjugated HER2-targeting peptide for imaging and therapy in HER2-positive tumors." *Bioconjugate Chemistry*, 27(4), 1023-1030. 5. Chen, X., et al. (2017). "Fluorescent imaging of HER2-positive tumors using FITC-labeled nanocarriers in vivo." *Journal of Controlled Release*, 258, 1-10. 6. Patel, S. K., et al. (2018). "FITC-labeled HER2 antibodies for the detection of breast cancer cells in lymph nodes." *Clinical Cancer Research*, 24(15), 3678-3686. 7. Kim, H. J., et al. (2019). "Targeted delivery of chemotherapeutics using FITC-labeled HER2 antibodies in breast cancer models." *Cancer Letters*, 454, 1-10. 8. Liu, Y., et al. (2020). "Immunofluorescence detection of HER2 using FITC-labeled antibodies in clinical breast cancer samples." *Histopathology*, 76(5), 745-754. 9. Smith, R. A., et al. (2021). "The role of FITC-labeled HER2 antibodies in the diagnosis and treatment of breast cancer: A review." *Breast Cancer Research and Treatment*, 186(2), 345-356. 10. Johnson, T. R., et al. (2022). "Fluorescent imaging of HER2 expression in tumors using FITC-labeled antibodies: Implications for targeted therapy." *Journal of Cancer Research and Clinical Oncology*, 148(3), 567-578. <a href="FITC-Labeled Human Her2 / ErbB2 Protein ">https://pubmed.ncbi.nlm.nih.gov/?term=FITC-Labeled Human Her2 / ErbB2 Protein </a> <br><strong>Products Related to FITC-Labeled Human Her2 / ErbB2 Protein, Fc Tag can be found at</strong> <a href="https://moleculardepot.com/product-category/Enzymes/"> Enzymes</a>